MedTrace Logo

Serum Calprotectin in Surgical Septic Patients

NCT06614088 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-09-26

No results posted yet for this study

Summary

To early evaluate the serum levels of calprotectin in patients suffering from intra-abdominal sepsis requiring a surgical treatment. The research project aims to investigate the role of serum calprotectin in the diagnosis of sepsis and to establish whether its level significantly correlates with different degree of disease severity and with short and long-term outcomes. If these associations were confirmed, serum calprotectin would represent an easily and rapidly detectable biomarker able to predict the severity of sepsis.

Conditions

  • Infection, Intraabdominal
  • Sepsis Abdominal
  • Biomarker

Interventions

DIAGNOSTIC_TEST

serum calprotectin

A blood sample is collected at time of admission to detect serum level of calprotectin

Sponsors & Collaborators

  • Azienda Ospedaliero, Universitaria Pisana

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2024-11-01
Completion
2025-01-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06614088 on ClinicalTrials.gov